28bio is a neurotechnology company that develops brain-on-a-chip platform designed to capture neurological processes.
28bio has raised $6.5M in total funding. The most recent round was Undisclosed. The last funding was announced in June 2025.
28bio's investors include National Institutes of Health, Benson Capital Partners, Laconia Ventures, Great Stuff Ventures, Center for the Advancement of Science in Space.
28bio is headquartered in Metairie, United States.
28bio is a neurotechnology company that develops brain-on-a-chip platform designed to capture neurological processes.
28bio is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"28bio — Funding & Investors." VCBacked, June 24, 2025, https://www.vcbacked.co/company/28bio. Accessed September 2, 2026.
VCBacked. (2025). 28bio — Funding & Investors. Retrieved September 2, 2026, from https://www.vcbacked.co/company/28bio
{{cite web |title=28bio — Funding & Investors |url=https://www.vcbacked.co/company/28bio |website=VCBacked |access-date=September 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated